IL216896A - Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects - Google Patents

Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects

Info

Publication number
IL216896A
IL216896A IL216896A IL21689611A IL216896A IL 216896 A IL216896 A IL 216896A IL 216896 A IL216896 A IL 216896A IL 21689611 A IL21689611 A IL 21689611A IL 216896 A IL216896 A IL 216896A
Authority
IL
Israel
Prior art keywords
metadoxine
adhd
compositions
add
treatment
Prior art date
Application number
IL216896A
Other languages
Hebrew (he)
Other versions
IL216896A0 (en
Original Assignee
Alcobra Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2010/000506 external-priority patent/WO2010150261A1/en
Application filed by Alcobra Ltd filed Critical Alcobra Ltd
Priority to IL216896A priority Critical patent/IL216896A/en
Publication of IL216896A0 publication Critical patent/IL216896A0/en
Publication of IL216896A publication Critical patent/IL216896A/en

Links

IL216896A 2009-06-25 2011-12-11 Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects IL216896A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL216896A IL216896A (en) 2009-06-25 2011-12-11 Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22037609P 2009-06-25 2009-06-25
US30564110P 2010-02-18 2010-02-18
PCT/IL2010/000506 WO2010150261A1 (en) 2009-06-25 2010-06-24 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
IL216896A IL216896A (en) 2009-06-25 2011-12-11 Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects

Publications (2)

Publication Number Publication Date
IL216896A0 IL216896A0 (en) 2012-02-29
IL216896A true IL216896A (en) 2016-09-29

Family

ID=45855179

Family Applications (1)

Application Number Title Priority Date Filing Date
IL216896A IL216896A (en) 2009-06-25 2011-12-11 Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects

Country Status (1)

Country Link
IL (1) IL216896A (en)

Also Published As

Publication number Publication date
IL216896A0 (en) 2012-02-29

Similar Documents

Publication Publication Date Title
ZA201205683B (en) Probiotic composition for use in the treatment of bowel inflammation
IL216582A0 (en) Composition for use in decreasing the transmission of human pathogens, devices comprising the same and uses thereof
EP2364161A4 (en) Compositions containing satiogens and methods of use
EP2361089A4 (en) Compositions and methods for the treatment of altered -synuclein function
IL208458A0 (en) Compositions and methods for skin care
HRP20160902T1 (en) Compositions and methods of use of phorbolesters
SI2185581T1 (en) Methods and compositions useful in the treatment of mucositis
EP2262469A4 (en) Skin care compositions and methods of use thereof
IL213410A0 (en) Methods and compositions for diagnostic use in cancer patients
EP2170404A4 (en) Compositions comprising human egfr-sirna and methods of use
EP2298365A4 (en) Medical composition and medical kit
EP2421901A4 (en) Compositions containing hc ha complex and methods of use thereof
HK1164369A1 (en) Preparation of microvesicle-sirna composition and use of the same in aids treatment
ZA201103065B (en) Preservation mixture and use thereof
PL2185581T3 (en) Methods and compositions useful in the treatment of mucositis
EP2342559A4 (en) Methods and compositions for preventing artifacts in tissue samples
HK1168793A1 (en) Glucose metabolism-improving agent and glucose metabolism-improving composition
GB2453671B (en) Preparation for use in the treatment of Clostridium difficile and Salmonella
ZA201004894B (en) Nuctraceutical composition and methods of use
IL216896A (en) Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects
EP2231173A4 (en) Nutraceutical composition and methods of use
GB2461611B (en) Composition and use thereof
HK1136303A1 (en) Formulation and use of ergosta-7,22-dien-3-ol -722--3-
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
EP2276502A4 (en) Compositions for the prevention and treatment of neuroinjury and methods of use thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees